pharmaphorum Podcast

In this new instalment of the pharmaphorum podcast, web editor Nicole Raleigh speaks with Dominic James, global head of digital health innovation and alliances at MSD on the topic of digital health.

In today's podcast, sponsored by Viseven, host Jonah Comstock welcomes Nataliya Andreychuk, Viseven's CEO, to talk about how AI is changing the world of pharma marketing, what opportunities she's most excited about, and some of the areas where the right execution of this new technology might be challenging.

Pharmaphorum Editor in Chief Jonah Comstock is joined on the podcast this week by friend-of-the-pod Eugene Borukhovich, who in addition to serving as COO of YourCoach Health also hosts the Digital Therapeutics Podcast, to discuss what they saw and heard at DtX East in Boston.

In today's podcast, sponsored by Oracle, host Jonah Comstock is joined by Otavio Clark, vice president of oncology at Cerner Enviza, an Oracle company, and Sheri McClerkin, an associate consultant in the Oncology & Specialty Therapeutics group at Cerner Enviza, to discuss the particular challenges of health inequity in the rare cancer space.

In this instalment of the pharmaphorum podcast, host Jonah Comstock welcomes Alchemab CEO Young Kwon, whose company has a different approach: starting with the healthiest of individuals and studying them to find out why they aren’t sick. Specifically, they’re looking through large data sets of healthy and disease-resistant people and looking for common antibodies that could help us all fight disea...

On today’s pharmaphorum podcast, Dr. Tim Church, chief medical officer at digital weight loss clinic Wondr Health joins Editor in Chief Jonah Comstock to chat about these new drugs, how they work, and how they're changing the game for patients.

In today’s episode, sponsored by Veeva, we’ll hear a roundtable discussion on this fascinating topic featuring Victoria Serra Gittermann, European customer experience lead at Veeva Systems and Sebastian Noel, Veeva’s director of multichannel strategy – moderating a discussion with two executives with first-hand experience leading this change: Andy Eeckhout, global head of CRM and digital solutions...

In a new episode of the pharmaphorum podcast, editor-in-chief Jonah Comstock speaks with Eugene Borukhovich, co-founder and COO of YourCoach Health, and Lyndi Hirsch, SVP of marketing strategy at Medisafe. Both companies specialise in digital health and, although different, entered into a partnership at the end of June.

In today’s podcast, Medable Chief Science Officer Dr. Pamela Tenaerts joins host Jonah Comstock to discuss the current state of regulations in DCTs and what’s currently lacking.

In a new pharmaphorum podcast, web editor Nicole Raleigh spoke with Michael Ibara, chief data officer at Elligo Health Research, discussing AI in clinical research and its overall impact on healthcare.

In the latest episode of the podcast, pharmaphorum Editor in Chief Jonah Comstock welcomes Dr. Alvaro Pascual-Leone, a neurology professor at Harvard Medical School, to the podcast to discuss how two new potentially groundbreaking Alzheimer's drugs work, describes the differences and similarities between them, and details both their exciting potential and their potential limitations. He also talks...

In this episode of the pharmaphorum podcast, web editor Nicole Raleigh speaks with André Deschamps, formerly president of Europa Uomo, the voice of men with prostate cancer in Europe. Deschamps is now involved in the Let’s Talk Prostate Cancer (LTPC) Expert Group, as well as the Belgian society, Wij Ook (part of Europa Uomo).

Recently, pharmaphorum web editor Nicole Raleigh spoke with Herbert Altmann, head of commercialisation and access solutions Europe at PharmaLex, and Casper Paardekooper, partner at Vintura. AmerisourceBergen completed the acquisition of PharmaLex (and Vintura, which was owned by PharmaLex).

In today’s podcast, Saad Harti, founder and CEO of Legacy Healthcare, joins Editor in Chief Jonah Comstock to discuss this exciting old, yet new category.  

Editor in Chief Jonah Comstock welcomes back returning guest Dr. Jennifer Jones-McMeans, divisional vice president for global affairs for Abbot’s vascular business. Jennifer was on the podcast just over a year ago to talk about the importance of clinical trial diversity, and she’s back with an update on that important topic, as well as some news from Abbott in that area.

In this episode of the pharmaphorum podcast, brought to you by Advanced Clinical, Advanced Clinical’s SVP Strategic Resourcing Steve Mattas and VP of Global Talent and Client Delivery James Nyssen speak with host Jonah Comstock about findings from a recent report by their company on the current personnel dynamics in pharma.

As DTx Europe came to a close at the British Medical Association in London, pharmaphorum web editor Nicole Raleigh spoke with Digital Medicine Society (DiMe) program lead, Alex Despotovic, discussing adoption of digital therapeutics and digital technologies in general in clinical practice, and the impact of the event itself overall.

Recently attending the Veeva R&D and Quality Summit in Madrid, pharmaphorum web editor Nicole Raleigh sat down with Veeva’s president of Europe, Chris Moore. The event seen as a chance to bring the whole industry together, Moore explained how there is an excitement in the industry currently, with more drugs being developed, more conditions being treated – including those not before addressed – and...

In the latest instalment of the pharmaphorum podcast, Editor in Chief Jonah Comstock is joined by Dr Noura Abul-Husn, VP of genomic health at 23andMe. 

This week, pharmaphorum editor-in-chief Jonah Comstock headed to not one but two back-to-back events in the US. Starting with the American Society of Clinical Oncology’s (ASCO) annual conference in Chicago, before hitting the floor at the BIO International Convention in Boston, there was plenty of innovation, news, and expert knowledge on display. Fresh from the floor of BIO International, Jonah s...

On the final day of Reuters Pharma Barcelona back in March, web editor Nicole Raleigh sat down with Graphite Digital’s CEO, Rob Verheul. The company – which has been working in the industry for 13 years now – has most recently been focusing on HCP engagement at a global scale, through use of digital channels.

In this episode of the pharmaphorum podcast, Editor in Chief Jonah Comstock catches up with Adityo Prakash, CEO of Verseon, to shed some light on what the potential of AI in drug discovery really is.

Back in March at Reuters Pharma Barcelona, pharmaphorum’s web editor Nicole Raleigh met up with CEO of Within3, Lance Hill. Having met up in Nice in 2022, it was interesting to ‘get up to speed’ a year later. Discussing how the industry is ‘starved’ of insights – with so much data from so many sources, fragmented, regional, and disconnected, that decisions cannot be reached in the timeframes neces...

 In the latest instalment of the pharmaphorum podcast, Editor in Chief Jonah Comstock connects with Kylie O’Keefe to talk about gene therapy in rare diseases.  They discuss what different gene therapies have in common and how some particular therapies work. They also talk about what gene therapy means for the industry and for patients, in particularly the paradigm shift of disease-modifying therap...

On 21st June, London’s prestigious Royal Society of Medicine will play host to some of the sharpest minds in healthcare as they come together for the inaugural World Without Disease conference, developed by pharmaphorum and the CWWDA. One of these minds is Daniel Zakowski, CEO of Ready, Set, Food!, who will be taking the stage to discuss why preventing childhood food allergies is an important step...